The emerging markets in CE, SE and Eastern Europe include Romania, Poland, Hungary, Turkey, Serbia.

The emerging markets in CE, SE and Eastern Europe include Romania, Poland, Hungary, Turkey, Serbia.
The emerging markets in CE, SE and Eastern Europe include Romania, Poland, Hungary, Turkey, Serbia, Lithuania.

Friday, 13 September 2013

Pharma market in Romania

The pharmaceutical company Johnson & Johnson Romania aims to increase its sales with 23% this year, up to 82 million EUR.


Ciprian Marcu, Romania & Bulgaria cluster head in the Japanese drug company Takeda Pharmaceuticals, says that by 2018 the company aims to launch ten new products.


The 40 largest local producers of drugs (including veterinary) recorded last year a combined turnover of 671 million euros and had 8166 employees.

According to Cegedim, the local pharmaceutical market could grow by 2.7% next year compared to 2013 and could exceed 2.7 billion euros.

The turnover of Terapia Ranbaxy, the largest producer of generic drugs in Romania, was in the first half of 2013 of 56 million euros, up 8% compared to the same period of 2012.

Drug sales reached 1.4 billion euros in the first six months of this year, an increase of 7% compared to the same period in 2012, according to data company IMS Health market.

Sources: ZF, Agerpres  

For market entry support, data collection and market research in Romania and the region, feel free to contact us with a RfP at europa@frdcenter.ro 

No comments:

Post a Comment

Note: only a member of this blog may post a comment.